Podcast
Questions and Answers
What is the primary goal of optimizing medicines?
What is the primary goal of optimizing medicines?
- To increase the frequency of medication reviews
- To promote the use of newer medicines over older ones
- To reduce the number of medicines taken by older people
- To ensure a person is taking their medicines as intended (correct)
What is the main purpose of the STOPP/START criteria?
What is the main purpose of the STOPP/START criteria?
- To reduce the number of medicines taken by older people
- To increase the frequency of medication reviews
- To identify potential prescribing omissions in older people (correct)
- To promote the use of newer medicines over older ones
What is the significance of the expansion of the STOPP/START criteria from version 2 to version 3?
What is the significance of the expansion of the STOPP/START criteria from version 2 to version 3?
- It reflects a reduction in the pharmacopeia and clinical trials evidence base
- It reflects an expansion of the pharmacopeia and clinical trials evidence base (correct)
- It reflects a change in the target population from older people to younger people
- It reflects a reduction in the number of prescribing omissions
What is the main difference between STOPP/START version 2 and version 3?
What is the main difference between STOPP/START version 2 and version 3?
What is the target population for the STOPP/START criteria?
What is the target population for the STOPP/START criteria?
Study Notes
Optimizing Medicines
- Optimizing medicines is crucial to ensure a person takes their medicines as intended, which can support the management of long-term conditions, multimorbidity, and polypharmacy.
STOPP/START Criteria
- The goal is to update and validate STOPP/START criteria for potentially inappropriate prescribing.
STOPP/START Version 3
- STOPP/START version 3 has been expanded and validated by an international European panel of experts in geriatric pharmacotherapy.
- Version 3 includes 190 criteria, significantly larger than version 2 (114 criteria).
- The expansion reflects the growth of the pharmacopeia and clinical trials evidence base relevant to older people since the publication of version 2.
Purpose of STOPP/START Version 3
- STOPP/START version 3 represents an updated explicit list of potentially inappropriate medications and potential prescribing omissions.
- The purpose is to optimize medication and minimize adverse drug reactions and events during medication review in older people, particularly those with multimorbidity and polypharmacy.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Update and validation of STOPP/START criteria for optimizing medicines, particularly for geriatric patients with long-term conditions, multimorbidity, and polypharmacy.